Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.